Loading data
Company
10x Genomics, Inc.
TXGNasdaq生命科学工具
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 642.82 m USD | 610.79 m USD | 618.73 m USD | 516.41 m USD | 490.49 m USD |
| Cost of revenue | 198.94 m USD | 196.3 m USD | 209.41 m USD | 120.39 m USD | 74.09 m USD |
| Gross profit | 443.88 m USD | 414.48 m USD | 409.31 m USD | 396.02 m USD | 416.4 m USD |
| Selling, general and administrative expense | 316.13 m USD | 344.34 m USD | 343.33 m USD | 298.3 m USD | 257.56 m USD |
| Operating profit | -60.99 m USD | -194.56 m USD | -265.33 m USD | -167.94 m USD | -52.25 m USD |
| Interest expense | — | — | 33 k USD | 476 k USD | 866 k USD |
| Profit before tax | -39.91 m USD | -177.7 m USD | -248.76 m USD | -161.97 m USD | -53.72 m USD |
| Income tax expense | 3.64 m USD | 4.93 m USD | 6.34 m USD | 4.03 m USD | 4.51 m USD |
| Net income (reported basis) | -43.5 m USD | -182.6 m USD | -255.1 m USD | -166 m USD | -58.2 m USD |
| Basic earnings per share | -0.35 USD/share | -1.52 USD/share | -2.18 USD/share | -1.46 USD/share | -0.53 USD/share |
| Diluted earnings per share | -0.35 USD/share | -1.52 USD/share | -2.18 USD/share | -1.46 USD/share | -0.53 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.